Cargando…

How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study

INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Jonathan, Ingabire, Charles, Umwiza, Francine, Gasana, Josephine, Munyaneza, Athanase, Murenzi, Gad, Nsanzimana, Sabin, Remera, Eric, Akiyama, Matthew J., Anastos, Kathryn M., Adedimeji, Adebola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118273/
https://www.ncbi.nlm.nih.gov/pubmed/33984044
http://dx.doi.org/10.1371/journal.pone.0251645
_version_ 1783691714957934592
author Ross, Jonathan
Ingabire, Charles
Umwiza, Francine
Gasana, Josephine
Munyaneza, Athanase
Murenzi, Gad
Nsanzimana, Sabin
Remera, Eric
Akiyama, Matthew J.
Anastos, Kathryn M.
Adedimeji, Adebola
author_facet Ross, Jonathan
Ingabire, Charles
Umwiza, Francine
Gasana, Josephine
Munyaneza, Athanase
Murenzi, Gad
Nsanzimana, Sabin
Remera, Eric
Akiyama, Matthew J.
Anastos, Kathryn M.
Adedimeji, Adebola
author_sort Ross, Jonathan
collection PubMed
description INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomatic, and they may view the relative benefits and risks of ART differently than those initiating at more advanced disease stages. To date, patient perspectives of initiating care under Treat All in sub-Saharan Africa have not been well described. METHODS: From September 2018 to March 2019, we conducted individual, semi-structured, qualitative interviews with 37 patients receiving HIV care in two health centers in Kigali, Rwanda. Data were analyzed using a mixed deductive and inductive thematic analysis approach to describe perceived barriers to, facilitators of and acceptability of initiating and adhering to ART rapidly under Treat All. RESULTS: Of 37 participants, 27 were women and the median age was 31 years. Participants described feeling traumatized and overwhelmed by their HIV diagnosis, resulting in difficulty accepting their HIV status. Most were prescribed ART soon after diagnosis, yet fear of lifelong medication and severe side effects in the immediate period after initiating ART led to challenges adhering to therapy. Moreover, because many PLWH initiated ART while healthy, taking medications and attending appointments were visible signals of HIV status and highly stigmatizing. Nonetheless, many participants expressed enthusiasm for Treat All as a program that improved health as well as health equity. CONCLUSION: For newly-diagnosed PLWH in Rwanda, initiating ART rapidly under Treat All presents logistical and emotional challenges despite the perceived benefits. Our findings suggest that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART.
format Online
Article
Text
id pubmed-8118273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81182732021-05-24 How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study Ross, Jonathan Ingabire, Charles Umwiza, Francine Gasana, Josephine Munyaneza, Athanase Murenzi, Gad Nsanzimana, Sabin Remera, Eric Akiyama, Matthew J. Anastos, Kathryn M. Adedimeji, Adebola PLoS One Research Article INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomatic, and they may view the relative benefits and risks of ART differently than those initiating at more advanced disease stages. To date, patient perspectives of initiating care under Treat All in sub-Saharan Africa have not been well described. METHODS: From September 2018 to March 2019, we conducted individual, semi-structured, qualitative interviews with 37 patients receiving HIV care in two health centers in Kigali, Rwanda. Data were analyzed using a mixed deductive and inductive thematic analysis approach to describe perceived barriers to, facilitators of and acceptability of initiating and adhering to ART rapidly under Treat All. RESULTS: Of 37 participants, 27 were women and the median age was 31 years. Participants described feeling traumatized and overwhelmed by their HIV diagnosis, resulting in difficulty accepting their HIV status. Most were prescribed ART soon after diagnosis, yet fear of lifelong medication and severe side effects in the immediate period after initiating ART led to challenges adhering to therapy. Moreover, because many PLWH initiated ART while healthy, taking medications and attending appointments were visible signals of HIV status and highly stigmatizing. Nonetheless, many participants expressed enthusiasm for Treat All as a program that improved health as well as health equity. CONCLUSION: For newly-diagnosed PLWH in Rwanda, initiating ART rapidly under Treat All presents logistical and emotional challenges despite the perceived benefits. Our findings suggest that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART. Public Library of Science 2021-05-13 /pmc/articles/PMC8118273/ /pubmed/33984044 http://dx.doi.org/10.1371/journal.pone.0251645 Text en © 2021 Ross et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ross, Jonathan
Ingabire, Charles
Umwiza, Francine
Gasana, Josephine
Munyaneza, Athanase
Murenzi, Gad
Nsanzimana, Sabin
Remera, Eric
Akiyama, Matthew J.
Anastos, Kathryn M.
Adedimeji, Adebola
How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title_full How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title_fullStr How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title_full_unstemmed How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title_short How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
title_sort how early is too early? challenges in art initiation and engaging in hiv care under treat all in rwanda—a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118273/
https://www.ncbi.nlm.nih.gov/pubmed/33984044
http://dx.doi.org/10.1371/journal.pone.0251645
work_keys_str_mv AT rossjonathan howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT ingabirecharles howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT umwizafrancine howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT gasanajosephine howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT munyanezaathanase howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT murenzigad howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT nsanzimanasabin howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT remeraeric howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT akiyamamatthewj howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT anastoskathrynm howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy
AT adedimejiadebola howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy